Randomized Trial: Efficacy of Fecal Microbiota Transplantation for Patients with Irritable Bowel Syndrome
7 Jan, 2020 | 01:40h | UTCRelated Articles: Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial – The Lancet Gastroenterology & Hepatology (link to abstract – $ for full-text) AND The effect of fecal microbiota transplantation on IBS related quality of life and fatigue in moderate to severe non-constipated irritable bowel: Secondary endpoints of a double blind, randomized, placebo-controlled trial – EbioMedicine (free)